statistiche ricercatore

Continente	#
NA - Nord America	658
AS - Asia	380
EU - Europa	285
SA - Sud America	80
Continente sconosciuto - Info sul continente non disponibili	13
AF - Africa	12
OC - Oceania	1
Totale	1.429

Nazione	#
US - Stati Uniti d'America	618
SG - Singapore	151
IT - Italia	74
CN - Cina	73
FI - Finlandia	72
BR - Brasile	69
BD - Bangladesh	52
DE - Germania	35
HK - Hong Kong	33
CA - Canada	29
VN - Vietnam	25
PL - Polonia	21
FR - Francia	18
GB - Regno Unito	14
TR - Turchia	14
NL - Olanda	11
RU - Federazione Russa	11
JP - Giappone	8
IE - Irlanda	7
UA - Ucraina	7
IN - India	6
MX - Messico	6
AR - Argentina	4
TW - Taiwan	4
CZ - Repubblica Ceca	3
VE - Venezuela	3
ZA - Sudafrica	3
AT - Austria	2
AZ - Azerbaigian	2
BE - Belgio	2
CR - Costa Rica	2
DZ - Algeria	2
ES - Italia	2
LT - Lituania	2
MA - Marocco	2
PK - Pakistan	2
SA - Arabia Saudita	2
AU - Australia	1
BF - Burkina Faso	1
BO - Bolivia	1
EC - Ecuador	1
EG - Egitto	1
ET - Etiopia	1
GM - Gambi	1
GY - Guiana	1
HN - Honduras	1
ID - Indonesia	1
IQ - Iraq	1
IR - Iran	1
JM - Giamaica	1
JO - Giordania	1
KZ - Kazakistan	1
LV - Lettonia	1
MN - Mongolia	1
NO - Norvegia	1
NP - Nepal	1
PH - Filippine	1
PY - Paraguay	1
SE - Svezia	1
SK - Slovacchia (Repubblica Slovacca)	1
SN - Senegal	1
SV - El Salvador	1
Totale	1.416

Nome	#
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy	379
Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study	195
Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine	137
Plasma levels of glial fibrillary acidic protein and neurofilament light chain in patients with chronic migraine: a multicenter case-control study	131
Neurological disorders throughout acute SARS-CoV2 infection: A comparative study between vaccinated and non-vaccinated patients	103
Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine	101
An observational study on monoclonal antibodies against calcitonin-gene-related peptide and its receptor	99
Migraine Disability and Severity Improvement during Long-Term Treatment with Erenumab	82
Photophobia and migraine outcome during treatment with galcanezumab	70
CGRP-monoclonal antibodies and SARS-CoV-2 vaccination	67
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients	65
Totale	1.429

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	15	0	0	0	2	0	1	1	2	0	2	3	4
2022/2023	21	2	3	0	2	2	5	0	0	5	1	0	1
2023/2024	28	2	0	5	2	3	8	0	1	3	0	1	3
2024/2025	306	2	0	0	53	21	19	27	29	27	28	58	42
2025/2026	791	63	76	32	88	73	79	144	35	45	45	37	74
2026/2027	144	26	20	36	62	0	0	0	0	0	0	0	0
Totale													1.429